OpenAI has invested in Merge Labs, a brain-computer interface (BCI) startup co-founded by OpenAI CEO Sam Altman. The startup ...

LumiMind debuts real-time non-invasive brain computer interfaces at CES 2026, pairing live gameplay demos with LumiSleep, a ...

In August, the Financial Times reported that OpenAI Chief Executive Officer Sam Altman is part of Merger Labs’ founding team ...

A major step toward the industrialization of brain-computer interface technology was taken recently as NeuroXess, a Chinese ...

The man is enrolled in the BrainGate2 clinical trial at UC Davis Health. His ability to communicate through a computer has ...

Signal Enhancement: An acoustic-driven signal enhancement approach based on NeRF acoustic field modeling and nested generative networks supplements missing or incomplete EEG data through acoustic ...

LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will showcase ...

The growing adoption of BCI technology is attributable to its rising awareness in treating a wide range of brain disorders. The growing incidences of brain disorders, stroke, depression, and Parkinson ...

Precision Neuroscience today announced a strategic partnership with Medtronic to leverage brain-computer interface (BCI) ...

OpenAI leads a major seed round in Sam Altman’s Merge Labs to develop advanced, non-invasive brain-computer interfaces with ...

The INSIDE Institute for NeuroAI has shared new results that show brain-computer interface (BCI) technology is now being used ...

Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego Synchron, a leader in non-surgical brain-computer interface ...